The MoU has been signed by Cardiff and Vale University Health Board, Cardiff University, Public Health Wales, and Illumina Cambridge, in collaboration with the Welsh Government, and supported by ...

Cambridge life science cluster’s most exciting companies, has gone through a huge overhaul in the boardroom – including a ...

Pykus Therapeutics, Inc. ("Pykus" or the "Company"), a clinical-stage medical technology company, announced today that it will present an overview of its investigational retinal sealant, PYK-2101, at ...

Armed with some data from our friends at CrunchBase, I broke down the largest US startup funding rounds from January 2025. I have included some additional information such as industry, company ...

She has spoken at the Wharton School of Business, Cambridge University Judge School ... Susan Tousi is Chief Commercial Officer at Illumina, where she leads global sales, commercial operations ...

Enabled on Illumina sequencers and a new multimodal analysis platform, Illumina's spatial technology delivers unbiased whole-transcriptome profiling with cellular resolution and high sensitivity.

Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China barred sales of the company’s gene-sequencing machines. San Diego ...

Illumina and next-gen sequencing (NGS) are synonymous. But to anyone paying attention, the company’s recent emphasis on multiomics has been hard to miss. Indeed, the company has launched both ...

(RTTNews) - Illumina, Inc. (ILMN) responded on Monday to the notice from the China Ministry of Commerce stating that it is not permitted to export sequencing instruments into China. Illumina said ...

Illumina is raising the curtain on its upcoming entry into spatial transcriptomics, with tech designed to help researchers explore cellular behavior mapped across complex tissues. The announcement ...